GlassScriptPhysician profile
David Ghozland
NPI 1750375929
$15,105.70
in general payments reported to CMS, 2019-2025
10 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,406 · 2020: $223 · 2021: $233 · 2023: $76.35 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $13K · Food and Beverage: $76.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $13,167.38 |
| Food and Beverage | $76.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $13,167.38 | 2025 | |
| Coloplast Corp | $844.88 | 2019 | |
| Abbvie INC. | $431.85 | 2019-2023 | |
| Galderma Laboratories, L.P. | $379.53 | 2019-2021 | |
| Allergan, INC. | $75.56 | 2019 | |
| Exeltis, USA INC. | $59.31 | 2019 | |
| Merck Sharp & Dohme LLC | $56.12 | 2019 | |
| Lupin INC. | $42.19 | 2019 | |
| Therapeuticsmd, INC. | $32.33 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ghozland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.